Count down 1 day! "Science war epidemic online forum" announces the complete agenda

"We need facts, we don't need panic; we need science, we don't need rumors; we need unity, not stigma." In the face of the epidemic, Dr Tan Desai, director general of the World Health Organization, has repeated this statement on several occasions, calling for global concerted efforts to fight against the new coronavirus At 9-12 a.m Beijing time on February 26 (5-8 p.m Pacific time on February 25 / 8-11 p.m Eastern time on February 25), Wuxi apptec will respond to the call of the World Health Organization to hold a global online thematic forum in both Chinese and English around covid-19 What have we learned from this epidemic? How can we speed up the development of diagnostic techniques, treatments, and vaccines? How can we better deal with the next possible outbreak of infectious diseases? Let's follow more than ten top experts around the world, listen to their views on these issues, and let rigorous scientific views guide us forward This online forum does not charge any participation fee, and provides simultaneous interpretation of the whole process in Chinese and English Thanks to Goldman Sachs, Morgan Stanley, Danaher, Huatai Securities, Huaxing capital, UBS group, Qiming venture capital, frost Sullivan, Deloitte and other partners for their support I would also like to thank zoom for providing full technical and platform support for the online forum Here is the latest agenda of the Forum (all Beijing time): Cai Hui, chairman of the forum, vice president of Wuxi apptec and head of content Department Zhang Feng, researcher, Howard Hughes Institute of medicine; core member, Broad Institute Charles Chiu, Professor of epidemiology / laboratory medicine and medicine, University of California, San Francisco (UCSF); Director, Center for diagnosis and discovery of Abbott virus Shi Chenyang, CEO of Addison medical laboratory; managing partner of Scarlett fund Moderator: Nick naclerio, founding partner of Illumina venture capital fund George scagos, CEO, vir Biotechnology Tomas cihlar, vice president, scientific virology, Gilead He Dayi, director of Aaron Diamond AIDS Research Center; Professor, Columbia University School of Medicine Chen Zhisheng, CEO of YaoMing biology; chairman of YaoMing Haide Moderator: Hong Zhi, co founder and CEO of tengshengbo pharmaceutical Gregory Poland, director of vaccine research, Mayo Clinic; editor in chief of vaccine Journal Johan van hoof, global director of infectious diseases and vaccines of Johnson & Johnson; head of vaccine & Prevention company of Johnson & Johnson Joseph Kim, President and CEO, inovio pharmaceuticals Yu Xuefeng, chairman and CEO of kangxinuo biology Mark Esser, vice president, microbial science, AstraZeneca Moderator: Yang Qing, executive vice president and chief commercial officer of Wuxi apptec Art reingord, director, Department of epidemiology and biostatistics, School of public health, University of California, Berkeley